XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Balance at Dec. 31, 2021 $ 85,617 $ 174 $ 1,048,936 $ (149) $ (964,342) $ 998
Balance (in shares) at Dec. 31, 2021   173,670        
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 2,138 $ 3 2,135      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   3,134        
Stock-based compensation 6,426   6,426      
Other comprehensive loss (1,486)     (1,486)    
Net loss (12,284)       (12,284)  
Balance at Mar. 31, 2022 80,411 $ 177 1,057,497 (1,635) (976,626) 998
Balance (in shares) at Mar. 31, 2022   176,804        
Balance at Dec. 31, 2022 68,562 $ 177 1,077,341 (2,787) (1,007,121) 952
Balance (in shares) at Dec. 31, 2022   177,582        
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 426 $ 3 423      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   2,890        
Stock-based compensation 5,669   5,669      
Other comprehensive loss 546     546    
Net loss (15,641)       (15,619) (22)
Balance at Mar. 31, 2023 $ 59,562 $ 180 $ 1,083,433 $ (2,241) $ (1,022,740) $ 930
Balance (in shares) at Mar. 31, 2023   180,472